Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Johnson and Johnson
Accenture
Fish and Richardson
Baxter
Colorcon
Cerilliant
Harvard Business School
Deloitte

Generated: July 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,293,273

« Back to Dashboard

Title:Controlled release and taste masking oral pharmaceutical composition
Abstract: Controlled release and taste masking compositions containing one or more active principles inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices. The use of a plurality of systems for the control of the dissolution of the active ingredient modulates the dissolution rate of the active ingredient in aqueous and/or biological fluids, thereby controlling the release kinetics in the gastrointestinal tract.
Inventor(s): Villa; Roberto (Lecco, IT), Pedrani; Massimo (Gignese, IT), Ajani; Mauro (Milan, IT), Fossati; Lorenzo (Milan, IT)
Assignee: Cosmo Technologies Limited (Dublin, IE)
Filing Date:May 02, 2012
Application Number:13/462,409
Claims:1. A controlled release oral pharmaceutical composition comprising: (1) a tablet core comprising: a) budesonide in an amount effective for treatment of inflammatory bowel disease in the gastrointestinal tract, b) stearic acid; c) lecithin; and d) hydroxypropyl cellulose; and (2) a gastro-resistant coating on said tablet core, said coating comprising at least one methacrylic acid polymer.

2. The composition of claim 1, wherein said tablet core further comprises microcrystalline cellulose, lactose, and magnesium stearate.

3. The composition of claim 1, comprising 9 mg of budesonide.

4. The composition of claim 2, comprising 9 mg of budesonide.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Deloitte
Moodys
Colorcon
Healthtrust
Dow
Daiichi Sankyo
QuintilesIMS
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.